Morgan Stanley
SKIN icon

Morgan Stanley’s SkinHealth Systems SKIN Stock Holding History

Morgan Stanley’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Sell
1,841
-1,450
-44% -$22.2K ﹤0.01% 6730
2026
Q1 		$58.6K Sell
3,291
-10,192
-76% -$250K ﹤0.01% 6367
2025
Q4 		$375K Buy
13,483
+4,403
+48% +$127K ﹤0.01% 5661
2025
Q3 		$361K Sell
9,080
-2,224
-20% -$90.3K ﹤0.01% 5638
2025
Q2 		$432K Buy
11,304
+3,896
+53% +$110K ﹤0.01% 5534
2025
Q1 		$199K Sell
7,408
-9,265
-56% -$283K ﹤0.01% 5727
2024
Q4 		$530K Buy
16,673
+2,689
+19% +$84.5K ﹤0.01% 5394
2024
Q3 		$403K Sell
13,984
-8,638
-38% -$283K ﹤0.01% 5503
2024
Q2 		$869K Sell
22,622
-107,170
-83% -$6.04M ﹤0.01% 5047
2024
Q1 		$11.5M Sell
129,792
-184,721
-59% -$12M ﹤0.01% 3229
2023
Q4 		$19.6M Buy
314,513
+291,691
+1,278% +$21.9M ﹤0.01% 2708
2023
Q3 		$2.75M Buy
22,822
+4,698
+26% +$660K ﹤0.01% 4174
2023
Q2 		$3.03M Sell
18,124
-15,296
-46% -$3.18M ﹤0.01% 4139
2023
Q1 		$8.44M Buy
33,420
+21,490
+180% +$4.97M ﹤0.01% 3300
2022
Q4 		$2.17M Sell
11,930
-45,784
-79% -$9.89M ﹤0.01% 4409
2022
Q3 		$13.6M Buy
57,714
+22,849
+66% +$5.78M ﹤0.01% 2624
2022
Q2 		$8.97M Buy
34,865
+25,580
+275% +$6.86M ﹤0.01% 3176
2022
Q1 		$3.13M Sell
9,285
-8,695
-48% -$2.87M ﹤0.01% 4159
2021
Q4 		$8.69M Sell
17,980
-1,664
-8% -$858K ﹤0.01% 3097
2021
Q3 		$10.2M Buy
19,644
+16,072
+450% +$7.07M ﹤0.01% 2869
2021
Q2 		$1.2M Buy
3,572
+2,759
+339% +$755K ﹤0.01% 4974
2021
Q1 		$176K Sell
813
-659
-45% -$145K ﹤0.01% 5729
2020
Q4 		$333K Buy
+1,472
New +$317K ﹤0.01% 5305

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's SKIN Position: Q2 2026 in Review

Morgan Stanley reduced its SkinHealth Systems (SKIN) stake by 44% in Q2 2026, selling an estimated $22.2K and leaving 1,841 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6730.

Morgan Stanley first reported a position in SKIN in Q4 2020 and has held it in 23 quarters since. The position peaked at $19.6M in Q4 2023. 93 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Morgan Stanley held 1,841 shares of SkinHealth Systems worth $25.5K as of Q2 2026.
  • Morgan Stanley sold 1,450 SkinHealth Systems shares in Q2 2026, an estimated $22.2K.
  • SkinHealth Systems made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6730 holding.
  • Morgan Stanley first reported a position in SkinHealth Systems in Q4 2020 and has held it in 23 quarters since.
  • Morgan Stanley's SkinHealth Systems position peaked at $19.6M in Q4 2023.
  • 93 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.